Shorena Janelidze
151 – 160 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- Contribution to journal › Article
-
Mark
The implications of different approaches to define AT(N) in Alzheimer disease
- Contribution to journal › Article
-
Mark
Plasma P-tau181 in Alzheimer’s disease : relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
- Contribution to journal › Article
- 2019
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Towards a unified protocol for handling of CSF before β-amyloid measurements
- Contribution to journal › Article
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
(2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235
- Contribution to journal › Article
-
Mark
CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
- Contribution to journal › Article
-
Mark
Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of extracellular matrix proteins in Alzheimer's disease
- Contribution to journal › Article
